Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Citi
Chubb
Deloitte
Baxter
US Department of Justice
Federal Trade Commission
Fish and Richardson
AstraZeneca

Generated: November 15, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: ANILERIDINE HYDROCHLORIDE

« Back to Dashboard

ANILERIDINE

CASRN: 144-14-9UNII: 71

Manufacturing Methods

<truncated in preview>

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Express Scripts
Citi
Healthtrust
Argus Health
Harvard Business School
Covington
Daiichi Sankyo
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.